OBJECTIVES: To evaluate the level of information and informed consent for maternal serum screening (MSS) for Down syndrome (DS) in the second trimester of pregnancy and analyse the exercise of autonomy towards the test by the women concerned. METHODS: We studied the population of pregnant women attending obstetric consultations in two French hospitals over a 3-month period. The women were assigned to three groups according to MSS results for DS: women at high risk of having a child with DS (group 1), women at low risk (group 2) and women who did not undergo the test (group 3). A questionnaire was completed before the medical consultation, to assess the quality of consent before amniocentesis for the group at high risk and before the second-...
Study Objective: Maternal serum screening is routinely offered to pregnant women in public hospitals...
International audienceBackground: To examine disparities by maternal place of birth in the opportuni...
In most Western countries, information on prenatal screening for Down syndrome is provided in the fi...
OBJECTIVES: To evaluate the level of information and informed consent for maternal serum screening (...
SummaryObjectiveRespect for patients' autonomy is a principle issue in medical ethics. Patients' und...
[[abstract]]Background: Although maternal serum screening (MSS) for Down's syndrome has become routi...
OBJECTIVES: We sought to evaluate socioeconomic disparities in serum screening for Down syndrome and...
To gain insight into how pregnant women experience serum screening for Down syndrome, we sent questi...
Objective: Evaluating the information provision procedure about prenatal screening for Down syndrome...
Abstract Background Down Syndrome screening test is a bridge between knowledge and uncertainty, safe...
Objective To determine the knowledge of pregnant women about prenatal tests. and what tests they wou...
Objective To determine the knowledge of pregnant women about prenatal tests, and what tests they wou...
Background: Different screening procedures are becoming an important part of health care. informatio...
Objectives: Prenatal screening for Down syndrome has become standard practice in many western countr...
Objectives: Prenatal screening for Down syndrome has become standard practice in many western countr...
Study Objective: Maternal serum screening is routinely offered to pregnant women in public hospitals...
International audienceBackground: To examine disparities by maternal place of birth in the opportuni...
In most Western countries, information on prenatal screening for Down syndrome is provided in the fi...
OBJECTIVES: To evaluate the level of information and informed consent for maternal serum screening (...
SummaryObjectiveRespect for patients' autonomy is a principle issue in medical ethics. Patients' und...
[[abstract]]Background: Although maternal serum screening (MSS) for Down's syndrome has become routi...
OBJECTIVES: We sought to evaluate socioeconomic disparities in serum screening for Down syndrome and...
To gain insight into how pregnant women experience serum screening for Down syndrome, we sent questi...
Objective: Evaluating the information provision procedure about prenatal screening for Down syndrome...
Abstract Background Down Syndrome screening test is a bridge between knowledge and uncertainty, safe...
Objective To determine the knowledge of pregnant women about prenatal tests. and what tests they wou...
Objective To determine the knowledge of pregnant women about prenatal tests, and what tests they wou...
Background: Different screening procedures are becoming an important part of health care. informatio...
Objectives: Prenatal screening for Down syndrome has become standard practice in many western countr...
Objectives: Prenatal screening for Down syndrome has become standard practice in many western countr...
Study Objective: Maternal serum screening is routinely offered to pregnant women in public hospitals...
International audienceBackground: To examine disparities by maternal place of birth in the opportuni...
In most Western countries, information on prenatal screening for Down syndrome is provided in the fi...